Pilot prospective evaluation of (18)F-FPPRGD2 PET/CT in patients with cervical and ovarian cancer.

about

Pilot prospective evaluation of (18)F-FPPRGD2 PET/CT in patients with cervical and ovarian cancer.

Item

http://www.wikidata.org/entity/Q40270232

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pilot prospective evaluation o ...... h cervical and ovarian cancer.

@en

type

Item

label

Pilot prospective evaluation o ...... h cervical and ovarian cancer.

@en

prefLabel

Pilot prospective evaluation o ...... h cervical and ovarian cancer.

@en

P1476

Pilot prospective evaluation o ...... h cervical and ovarian cancer.

@en

P2093

Amer Karam

http://www.w3.org/2001/XMLSchema#string

Amir Barkhodari

http://www.w3.org/2001/XMLSchema#string

Andrei Iagaru

http://www.w3.org/2001/XMLSchema#string

Mehran Jamali

http://www.w3.org/2001/XMLSchema#string

Oliver Dorigo

http://www.w3.org/2001/XMLSchema#string

Ryogo Minamimoto

http://www.w3.org/2001/XMLSchema#string

Sanjiv Sam Gambhir

http://www.w3.org/2001/XMLSchema#string

P2860

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

Angiogenesis in cancer and other diseases

Role of angiogenesis in tumor growth and metastasis

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

Requirement of vascular integrin alpha v beta 3 for angiogenesis

18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.

Glioblastoma Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2 PET/CT.

Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies.

Improved survival with bevacizumab in advanced cervical cancer

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

P2888

s00259-015-3263-7

P304

1047-1055

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-015-3263-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26611425

http://www.w3.org/2001/XMLSchema#string